ARYL HYDANTOIN HETEROCYCLES AND METHODS OF USE

Disclosed is a compound of formula (I) in which R1, R2, R3, X1, X2, X2′, X3, X4, ring A, m, n, and o are as described herein. The compound of formula (I) is useful for treating a disorder associated with androgen receptor malfunction, such as a hyperproliferative disorder, in a subject in need there...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: FIGG, SR., William Douglas, TAPADAR, Subhasish, OYELERE, Adegboyega K, GRYDER, Berkley E, STROPE, Jonathan D
Format: Patent
Sprache:eng ; fre ; ger
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator FIGG, SR., William Douglas
TAPADAR, Subhasish
OYELERE, Adegboyega K
GRYDER, Berkley E
STROPE, Jonathan D
description Disclosed is a compound of formula (I) in which R1, R2, R3, X1, X2, X2′, X3, X4, ring A, m, n, and o are as described herein. The compound of formula (I) is useful for treating a disorder associated with androgen receptor malfunction, such as a hyperproliferative disorder, in a subject in need thereof.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP4093512A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP4093512A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP4093512A13</originalsourceid><addsrcrecordid>eNrjZNBzDIr0UfCIdHH0C_H39FPwcA1xDfJ3jnT2cQ1WcPRzUfB1DfHwdwlW8HdTCA125WFgTUvMKU7lhdLcDApuriHOHrqpBfnxqcUFicmpeakl8a4BJgaWxqaGRo6GxkQoAQCaAiVG</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>ARYL HYDANTOIN HETEROCYCLES AND METHODS OF USE</title><source>esp@cenet</source><creator>FIGG, SR., William Douglas ; TAPADAR, Subhasish ; OYELERE, Adegboyega K ; GRYDER, Berkley E ; STROPE, Jonathan D</creator><creatorcontrib>FIGG, SR., William Douglas ; TAPADAR, Subhasish ; OYELERE, Adegboyega K ; GRYDER, Berkley E ; STROPE, Jonathan D</creatorcontrib><description>Disclosed is a compound of formula (I) in which R1, R2, R3, X1, X2, X2′, X3, X4, ring A, m, n, and o are as described herein. The compound of formula (I) is useful for treating a disorder associated with androgen receptor malfunction, such as a hyperproliferative disorder, in a subject in need thereof.</description><language>eng ; fre ; ger</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20221130&amp;DB=EPODOC&amp;CC=EP&amp;NR=4093512A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76318</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20221130&amp;DB=EPODOC&amp;CC=EP&amp;NR=4093512A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>FIGG, SR., William Douglas</creatorcontrib><creatorcontrib>TAPADAR, Subhasish</creatorcontrib><creatorcontrib>OYELERE, Adegboyega K</creatorcontrib><creatorcontrib>GRYDER, Berkley E</creatorcontrib><creatorcontrib>STROPE, Jonathan D</creatorcontrib><title>ARYL HYDANTOIN HETEROCYCLES AND METHODS OF USE</title><description>Disclosed is a compound of formula (I) in which R1, R2, R3, X1, X2, X2′, X3, X4, ring A, m, n, and o are as described herein. The compound of formula (I) is useful for treating a disorder associated with androgen receptor malfunction, such as a hyperproliferative disorder, in a subject in need thereof.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNBzDIr0UfCIdHH0C_H39FPwcA1xDfJ3jnT2cQ1WcPRzUfB1DfHwdwlW8HdTCA125WFgTUvMKU7lhdLcDApuriHOHrqpBfnxqcUFicmpeakl8a4BJgaWxqaGRo6GxkQoAQCaAiVG</recordid><startdate>20221130</startdate><enddate>20221130</enddate><creator>FIGG, SR., William Douglas</creator><creator>TAPADAR, Subhasish</creator><creator>OYELERE, Adegboyega K</creator><creator>GRYDER, Berkley E</creator><creator>STROPE, Jonathan D</creator><scope>EVB</scope></search><sort><creationdate>20221130</creationdate><title>ARYL HYDANTOIN HETEROCYCLES AND METHODS OF USE</title><author>FIGG, SR., William Douglas ; TAPADAR, Subhasish ; OYELERE, Adegboyega K ; GRYDER, Berkley E ; STROPE, Jonathan D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP4093512A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2022</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>FIGG, SR., William Douglas</creatorcontrib><creatorcontrib>TAPADAR, Subhasish</creatorcontrib><creatorcontrib>OYELERE, Adegboyega K</creatorcontrib><creatorcontrib>GRYDER, Berkley E</creatorcontrib><creatorcontrib>STROPE, Jonathan D</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>FIGG, SR., William Douglas</au><au>TAPADAR, Subhasish</au><au>OYELERE, Adegboyega K</au><au>GRYDER, Berkley E</au><au>STROPE, Jonathan D</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>ARYL HYDANTOIN HETEROCYCLES AND METHODS OF USE</title><date>2022-11-30</date><risdate>2022</risdate><abstract>Disclosed is a compound of formula (I) in which R1, R2, R3, X1, X2, X2′, X3, X4, ring A, m, n, and o are as described herein. The compound of formula (I) is useful for treating a disorder associated with androgen receptor malfunction, such as a hyperproliferative disorder, in a subject in need thereof.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre ; ger
recordid cdi_epo_espacenet_EP4093512A1
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title ARYL HYDANTOIN HETEROCYCLES AND METHODS OF USE
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T16%3A44%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=FIGG,%20SR.,%20William%20Douglas&rft.date=2022-11-30&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP4093512A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true